The federal judge who ruled last month that the Affordable Care Act (ACA) was invalid issued an order over the weekend that the law will remain in effect pending appeal; pharmacies and businesses with pharmacies in New York City will no longer be allowed to sell cigarettes and other tobacco products; a federal judge has blocked the administration's cut to the 340B program.
The federal judge who ruled last month that the Affordable Care Act was unconstitutional issued a stay over the weekend, which will keep the law in effect while the ruling is appealed. According to The New York Times, Judge Reed O’Connor of the Federal District Court in Fort Worth, Texas, said that the ruling would not go into immediate effect “because many everyday Americans would otherwise face great uncertainty” during the appeal.
Starting this week, pharmacies and businesses that contain pharmacies, such as supermarkets, will be banned from selling cigarettes and other tobacco products in New York City, reported The Wall Street Journal. Affecting approximately 500 pharmacies, the change will reduce the total number of retailers licensed to sell tobacco by about 6.4%. Health officials in the city praised the decision, calling it an important step in reducing the number of smokers in New York.A federal judge has blocked the Trump administration’s cut to the 340B Drug Discount Program, ruling that the administration illegally reduced Medicare payments to the program and that the rule went against Congress’s intent when it approved the program, reported The Hill. The rule, which went into effect last January, cut payments by 30%. When the rule was issued, the administration argued that the changes would reduce out-of-pocket costs Medicare patients pay for outpatient drugs. However, hospitals argued that the changes would threaten critical services they provide to underserved populations.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More